These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 17291936)
21. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. Taddei S; Versari D; Cipriano A; Ghiadoni L; Galetta F; Franzoni F; Magagna A; Virdis A; Salvetti A J Am Coll Cardiol; 2006 Aug; 48(3):508-15. PubMed ID: 16875977 [TBL] [Abstract][Full Text] [Related]
22. Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans. Nishioka K; Hidaka T; Nakamura S; Umemura T; Jitsuiki D; Soga J; Goto C; Chayama K; Yoshizumi M; Higashi Y Hypertens Res; 2007 Sep; 30(9):775-80. PubMed ID: 18037769 [TBL] [Abstract][Full Text] [Related]
23. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels. Rivera P; Ocaranza MP; Lavandero S; Jalil JE Hypertension; 2007 Oct; 50(4):792-8. PubMed ID: 17785632 [TBL] [Abstract][Full Text] [Related]
25. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. John S; Schneider MP; Delles C; Jacobi J; Schmieder RE Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218 [TBL] [Abstract][Full Text] [Related]
26. Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle. Schrage WG; Dietz NM; Eisenach JH; Joyner MJ J Appl Physiol (1985); 2005 Apr; 98(4):1251-7. PubMed ID: 15563630 [TBL] [Abstract][Full Text] [Related]
27. Effect of fasudil on macrovascular disorder-induced endothelial dysfunction. Shah DI; Singh M Can J Physiol Pharmacol; 2006; 84(8-9):835-45. PubMed ID: 17111028 [TBL] [Abstract][Full Text] [Related]
28. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo. Yada T; Shimokawa H; Hiramatsu O; Kajita T; Shigeto F; Tanaka E; Shinozaki Y; Mori H; Kiyooka T; Katsura M; Ohkuma S; Goto M; Ogasawara Y; Kajiya F J Am Coll Cardiol; 2005 Feb; 45(4):599-607. PubMed ID: 15708710 [TBL] [Abstract][Full Text] [Related]
29. Nitric oxide does not downregulate Rho-kinase (ROCK-2) expression in rat coronary endothelial cells. Tiftik RN; Erol A; Cnar MG; Kubat H; Ark M; Ulker S; Büyükafşar K J Cardiovasc Pharmacol; 2008 Feb; 51(2):140-7. PubMed ID: 18287881 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats. Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670 [TBL] [Abstract][Full Text] [Related]
31. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Santos-Parker JR; Strahler TR; Bassett CJ; Bispham NZ; Chonchol MB; Seals DR Aging (Albany NY); 2017 Jan; 9(1):187-208. PubMed ID: 28070018 [TBL] [Abstract][Full Text] [Related]
33. Rho kinase inhibition by fasudil exerts antioxidant effects in hypercholesterolemic rats. Ma Z; Zhang J; Ji E; Cao G; Li G; Chu L Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):688-94. PubMed ID: 21711379 [TBL] [Abstract][Full Text] [Related]
34. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785 [TBL] [Abstract][Full Text] [Related]
35. Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes. Woodman RJ; Watts GF; Playford DA; Best JD; Chan DC Diabetes Obes Metab; 2005 Sep; 7(5):612-7. PubMed ID: 16050955 [TBL] [Abstract][Full Text] [Related]
37. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans. Stewart AD; Millasseau SC; Kearney MT; Ritter JM; Chowienczyk PJ Hypertension; 2003 Nov; 42(5):915-8. PubMed ID: 12975386 [TBL] [Abstract][Full Text] [Related]
38. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature. Lauer T; Kleinbongard P; Preik M; Rauch BH; Deussen A; Feelisch M; Strauer BE; Kelm M Basic Res Cardiol; 2003 Mar; 98(2):84-9. PubMed ID: 12607129 [TBL] [Abstract][Full Text] [Related]
39. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596 [TBL] [Abstract][Full Text] [Related]
40. Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide. Büssemaker E; Pistrosch F; Förster S; Herbrig K; Gross P; Passauer J; Brandes RP Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H541-7. PubMed ID: 17384125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]